261 related articles for article (PubMed ID: 33768673)
1. Cell-type specific expression and behavioral impact of galanin and GalR1 in the locus coeruleus during opioid withdrawal.
Foster SL; Galaj E; Karne SL; Ferré S; Weinshenker D
Addict Biol; 2021 Sep; 26(5):e13037. PubMed ID: 33768673
[TBL] [Abstract][Full Text] [Related]
2. Lack of effect of chronic morphine treatment and naloxone-precipitated withdrawal on tyrosine hydroxylase, galanin, and neuropeptide Y mRNA levels in the rat locus coeruleus.
Holmes PV; de Bartolomeis A; Koprivica V; Crawley JN
Synapse; 1995 Mar; 19(3):197-205. PubMed ID: 7540319
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of galanin binding sites and GalR1 mRNA levels in the mouse locus coeruleus following chronic morphine treatments and precipitated morphine withdrawal.
Zachariou V; Thome J; Parikh K; Picciotto MR
Neuropsychopharmacology; 2000 Aug; 23(2):127-37. PubMed ID: 10882839
[TBL] [Abstract][Full Text] [Related]
4. Influence of chronic administration of antidepressant drugs on mRNA for galanin, galanin receptors, and tyrosine hydroxylase in catecholaminergic and serotonergic cell-body regions in rat brain.
Rovin ML; Boss-Williams KA; Alisch RS; Ritchie JC; Weinshenker D; West CH; Weiss JM
Neuropeptides; 2012 Apr; 46(2):81-91. PubMed ID: 22317959
[TBL] [Abstract][Full Text] [Related]
5. Characterization of GalR1, GalR2, and GalR3 immunoreactivity in catecholaminergic nuclei of the mouse brain.
Hawes JJ; Picciotto MR
J Comp Neurol; 2004 Nov; 479(4):410-23. PubMed ID: 15514977
[TBL] [Abstract][Full Text] [Related]
6. Galanin negatively modulates opiate withdrawal via galanin receptor 1.
Holmes FE; Armenaki A; Iismaa TP; Einstein EB; Shine J; Picciotto MR; Wynick D; Zachariou V
Psychopharmacology (Berl); 2012 Apr; 220(3):619-25. PubMed ID: 21969124
[TBL] [Abstract][Full Text] [Related]
7. Possible involvement of the locus coeruleus in inhibition by prostanoid EP(3) receptor-selective agonists of morphine withdrawal syndrome in rats.
Nakagawa T; Masuda T; Watanabe T; Minami M; Satoh M
Eur J Pharmacol; 2000 Mar; 390(3):257-66. PubMed ID: 10708732
[TBL] [Abstract][Full Text] [Related]
8. Neuronal diversity of neuropeptide signaling, including galanin, in the mouse locus coeruleus.
Caramia M; Romanov RA; Sideromenos S; Hevesi Z; Zhao M; Krasniakova M; Xu ZD; Harkany T; Hökfelt TGM
Proc Natl Acad Sci U S A; 2023 Aug; 120(31):e2222095120. PubMed ID: 37487094
[TBL] [Abstract][Full Text] [Related]
9. Suppression of acute and chronic opioid withdrawal by a selective soluble guanylyl cyclase inhibitor.
Sullivan ME; Hall SR; Milne B; Jhamandas K
Brain Res; 2000 Mar; 859(1):45-56. PubMed ID: 10720614
[TBL] [Abstract][Full Text] [Related]
10. Clonidine infusions into the locus coeruleus attenuate behavioral and neurochemical changes associated with naloxone-precipitated withdrawal.
Taylor JR; Elsworth JD; Garcia EJ; Grant SJ; Roth RH; Redmond DE
Psychopharmacology (Berl); 1988; 96(1):121-34. PubMed ID: 3147472
[TBL] [Abstract][Full Text] [Related]
11. Activation of galanin receptor 1 inhibits locus coeruleus neurons via GIRK channels.
Bai YF; Ma HT; Liu LN; Li H; Li XX; Yang YT; Xue B; Wang D; Xu ZD
Biochem Biophys Res Commun; 2018 Sep; 503(1):79-85. PubMed ID: 29852172
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide synthase inhibitors attenuate acute and chronic morphine withdrawal response in the rat locus coeruleus: an in vivo voltammetric study.
Hall S; Milne B; Jhamandas K
Brain Res; 1996 Nov; 739(1-2):182-91. PubMed ID: 8955938
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the effects of clonidine and CNQX infusion into the locus coeruleus and the amygdala on naloxone-precipitated opiate withdrawal in the rat.
Taylor JR; Punch LJ; Elsworth JD
Psychopharmacology (Berl); 1998 Jul; 138(2):133-42. PubMed ID: 9718282
[TBL] [Abstract][Full Text] [Related]
14. Distinct features of neurotransmitter systems in the human brain with focus on the galanin system in locus coeruleus and dorsal raphe.
Le Maître E; Barde SS; Palkovits M; Diaz-Heijtz R; Hökfelt TG
Proc Natl Acad Sci U S A; 2013 Feb; 110(6):E536-45. PubMed ID: 23341594
[TBL] [Abstract][Full Text] [Related]
15. Galanin inhibits tyrosine hydroxylase expression in midbrain dopaminergic neurons.
Counts SE; McGuire SO; Sortwell CE; Crawley JN; Collier TJ; Mufson EJ
J Neurochem; 2002 Oct; 83(2):442-51. PubMed ID: 12423254
[TBL] [Abstract][Full Text] [Related]
16. Galanin/GMAP- and NPY-like immunoreactivities in locus coeruleus and noradrenergic nerve terminals in the hippocampal formation and cortex with notes on the galanin-R1 and -R2 receptors.
Xu ZQ; Shi TJ; Hökfelt T
J Comp Neurol; 1998 Mar; 392(2):227-51. PubMed ID: 9512271
[TBL] [Abstract][Full Text] [Related]
17. Intraventricular administration of galanin does not affect behaviors associated with locus coeruleus activation in rats.
Holmes PV; Koprivica V; Chough E; Crawley JN
Peptides; 1994; 15(7):1303-8. PubMed ID: 7531843
[TBL] [Abstract][Full Text] [Related]
18. Local opiate withdrawal in locus coeruleus neurons in vitro.
Ivanov A; Aston-Jones G
J Neurophysiol; 2001 Jun; 85(6):2388-97. PubMed ID: 11387385
[TBL] [Abstract][Full Text] [Related]
19. Co-released norepinephrine and galanin act on different timescales to promote stress-induced anxiety-like behavior.
Tillage RP; Foster SL; Lustberg D; Liles LC; McCann KE; Weinshenker D
Neuropsychopharmacology; 2021 Jul; 46(8):1535-1543. PubMed ID: 33911187
[TBL] [Abstract][Full Text] [Related]
20. Tyrosine hydroxylase and galanin mRNA levels in locus coeruleus neurons are increased following reserpine administration.
Austin MC; Cottingham SL; Paul SM; Crawley JN
Synapse; 1990; 6(4):351-7. PubMed ID: 1705056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
